ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

Heidelberger Wins $100,000 Award

September 17, 1982

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

NCI expands program to promote healthy diet among African Americans.

September 24, 2004